News & Analysis as of

Intellectual Property Protection Regulatory Requirements Investors

Offit Kurman

Patents and the FDA: Four Critical Considerations Medical Device Companies Must Know to Successfully Introduce New Products into...

Offit Kurman on

The intersection of patent strategy and FDA regulatory strategy is a critical consideration for medical device companies. A well-integrated approach can create powerful barriers to entry, strengthen intellectual property (IP)...more

Buckingham, Doolittle & Burroughs, LLC

Breaking Into the U.S. Market: Why Legal Guidance is Your First Investment

Expanding into the U.S. is a major milestone for many foreign companies. With its large consumer base, strong legal protections, and global influence, the United States remains one of the most attractive markets in the world....more

White & Case LLP

AI Watch: Global regulatory tracker

White & Case LLP on

The global dash to regulate AI - Artificial intelligence (AI) has made enormous strides in recent years and has increasingly moved into the public consciousness. Increases in computational power, coupled with advances in...more

Foley & Lardner LLP

AI Regulatory and Legal Issues Today: A Conversation with Natasha Allen

Foley & Lardner LLP on

As is the case with most emerging technologies, developments in artificial intelligence (AI) are quickly outpacing regulations, and with this comes a variety of important legal considerations. While there has been a push for...more

Bailey & Glasser, LLP

[Webinar] From Beeple to Billions - What You Need To Know About NFTs - June 21st, 2:00 pm - 2:45 pm ET

Bailey & Glasser, LLP on

An NFT is one-of-a-kind digital asset that belongs to you and you alone – and some are selling for jaw-dropping prices. In November 2021, Christie’s auction house sold the first-ever NFT artwork by digital artist Beeple for...more

McDermott Will & Schulte

[Event] 2019 Life Sciences Dealmaking Symposium - October 15th - 16th, Cambridge, MA

Opportunities abound for dealmakers who can navigate the ever-changing global life sciences deal landscape. However, the transformative transactions shaping today’s hottest life sciences growth sectors also can present...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide